InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Gebski Christine, Executive. Insider active across 2 companies, notably Repligen CORP. Cumulatively, 18 disclosures have been recorded. Split: 0 buy · 6 sells. Total volume traded: €3.1m. History available since 14 May 2021. The latest transaction was disclosed on 14 May 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations18 total
334 shares@ US$163.342.0% of flowCommon StockSEC:0000950170-24-060747:0
386 shares@ US$195.722.8% of flowCommon StockSEC:0000950170-24-027993:0
131 shares@ US$193.990.9% of flowCommon StockSEC:0000950170-24-027505:0
391 shares0Common StockSEC:0000950170-24-025296:0
3,788 shares@ US$147.1321.1% of flowCommon StockSEC:0000950170-23-063113:0
334 shares@ US$154.031.9% of flowCommon StockSEC:0000950170-23-022580:0
3,467 shares0Common StockSEC:0000899243-23-007196:0
460 shares@ US$173.283.0% of flowCommon StockSEC:0000899243-23-006765:0
452 shares@ US$173.443.0% of flowCommon StockSEC:0000899243-23-006506:0
3,357 shares@ US$243.0132.2% of flowCommon StockSEC:0000899243-22-027833:0
335 shares@ US$150.400.0008% mcap4.5% of flowCommon StockSEC:0000899243-22-018417:0
462 shares@ US$196.700.0014% mcap7.6% of flowCommon StockSEC:0000899243-22-008747:0
2,124 shares0Common StockSEC:0000899243-22-008177:0
450 shares0Common StockSEC:0000899243-22-007256:0
3,377 shares@ US$285.330.014% mcap76.0% of flowCommon StockSEC:0000899243-21-034901:0
3,377 shares@ US$285.3332.9% of flowCommon StockSEC:0000899243-21-034901
445 shares@ US$172.250.0011% mcap5.9% of flowCommon StockSEC:0000899243-21-019723:0
445 shares@ US$172.255.9% of flowCommon StockSEC:0000899243-21-019723
18 of 18 declarations
About Gebski Christine
Christine Gebski is an Executive at REPLIGEN CORP. In this role, she participates in the strategic leadership of the company. REPLIGEN CORP is a company specializing in biopharmaceutical solutions. Christine Gebski brings valuable expertise in biotechnology and business management.
